Indian Immunologicals Limited collaboratively develops game-changing needle-free COVID-19 Intranasal Vaccine
Hyderabad, Aug 27 (Maxim News): Indian Immunologicals Limited has announced a live-attenuated needle-free intranasal booster vaccine developed against SARS-CoV-2 using codon deoptimization technology in collaboration with Griffith University, Australia.
Click Here To Join Us On WhatsApp
This groundbreaking work on the COVID-19 vaccine was published in the world’s leading science Journal ‘Nature Communications‘ on 26th August 2024.
A press release said that the danger due to COVID-19 is still not over and it is still killing around 1,700 people a week around the world. Among the different formats of vaccines available, it is well known that live attenuated vaccines generate a robust and broad-spectrum neutralizing antibody response.
Click Here To Join Us On WhatsApp
IIL’s needle-free intranasal booster vaccine against SARS-CoV-2 developed using codon deoptimization technology demonstrated remarkable stability and maintained safety in extensive animal studies, the press release said. (Maxim News)
More Stories :
-
Big Relief To Revanth Reddy By Supreme Court In Vote-For-Note Case
In a crucial development which has taken place in the sensational Vote-for-Note case. The Supreme Court issued important orders on this case today (Friday), A bench of Justice BR Gavai and Justice KV Vishwanath made it clear that the case will not be transferred to Madhya Pradesh.
Now you can get the latest stories from Indtoday on Telegram every day. Click the link to subscribe. Click to follow Indtoday’s Facebook page, Twitter and Instagram. For all the latest Hyderabad News update